NeuPD-A Neural Network-Based Approach to Predict Antineoplastic Drug Response
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shahzad, Muhammad | - |
dc.contributor.author | Tahir, Muhammad Atif | - |
dc.contributor.author | Alhussein, Musaed | - |
dc.contributor.author | Mobin, Ansharah | - |
dc.contributor.author | Malick, Rauf Ahmed Shams | - |
dc.contributor.author | Anwar, Muhammad Shahid | - |
dc.date.accessioned | 2023-07-22T16:40:18Z | - |
dc.date.available | 2023-07-22T16:40:18Z | - |
dc.date.created | 2023-07-21 | - |
dc.date.issued | 2023-06 | - |
dc.identifier.issn | 2075-4418 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/88576 | - |
dc.description.abstract | With the beginning of the high-throughput screening, in silico-based drug response analysis has opened lots of research avenues in the field of personalized medicine. For a decade, many different predicting techniques have been recommended for the antineoplastic (anti-cancer) drug response, but still, there is a need for improvements in drug sensitivity prediction. The intent of this research study is to propose a framework, namely NeuPD, to validate the potential anti-cancer drugs against a panel of cancer cell lines in publicly available datasets. The datasets used in this work are Genomics of Drug Sensitivity in Cancer (GDSC) and Cancer Cell Line Encyclopedia (CCLE). As not all drugs are effective on cancer cell lines, we have worked on 10 essential drugs from the GDSC dataset that have achieved the best modeling results in previous studies. We also extracted 1610 essential oncogene expressions from 983 cell lines from the same dataset. Whereas, from the CCLE dataset, 16,383 gene expressions from 1037 cell lines and 24 drugs have been used in our experiments. For dimensionality reduction, Pearson correlation is applied to best fit the model. We integrate the genomic features of cell lines and drugs' fingerprints to fit the neural network model. For evaluation of the proposed NeuPD framework, we have used repeated K-fold cross-validation with 5 times repeats where K = 10 to demonstrate the performance in terms of root mean square error (RMSE) and coefficient determination (R-2). The results obtained on the GDSC dataset that were measured using these cost functions show that our proposed NeuPD framework has outperformed existing approaches with an RMSE of 0.490 and R-2 of 0.929. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.relation.isPartOf | DIAGNOSTICS | - |
dc.title | NeuPD-A Neural Network-Based Approach to Predict Antineoplastic Drug Response | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 001014130600001 | - |
dc.identifier.doi | 10.3390/diagnostics13122043 | - |
dc.identifier.bibliographicCitation | DIAGNOSTICS, v.13, no.12 | - |
dc.description.isOpenAccess | Y | - |
dc.identifier.scopusid | 2-s2.0-85163977537 | - |
dc.citation.title | DIAGNOSTICS | - |
dc.citation.volume | 13 | - |
dc.citation.number | 12 | - |
dc.contributor.affiliatedAuthor | Anwar, Muhammad Shahid | - |
dc.type.docType | Article | - |
dc.subject.keywordAuthor | NeuPD | - |
dc.subject.keywordAuthor | cell lines | - |
dc.subject.keywordAuthor | gene expression | - |
dc.subject.keywordAuthor | machine learning | - |
dc.subject.keywordAuthor | neural networks | - |
dc.subject.keywordAuthor | drug response prediction | - |
dc.subject.keywordAuthor | XGBoost | - |
dc.subject.keywordPlus | SENSITIVITY | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.relation.journalResearchArea | General & Internal Medicine | - |
dc.relation.journalWebOfScienceCategory | Medicine, General & Internal | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.